腸内細菌叢の世界市場レポート 2025年

腸内細菌叢市場規模は、今後数年で急成長が見込まれます。2029年の年間平均成長率（CAGR）は18.2％で、12億7,000万米ドルに成長します。予測期間の成長は、個別化栄養学の拡大、微生物ベースの治療薬に対する需要の高まり、機能性食品と発酵食品の成長、プロバイオティクスとプレバイオティクスに対する規制支援に起因すると考えられます。予測期間における主な動向としては、AIを活用したマイクロバイオーム解析、次世代シーケンサーの進歩、CRISPRを活用した腸内細菌叢編集、スマートプロバイオティクスデリバリーシステムの開発、ウェアラブル腸内健康モニタリングデバイスの出現などが挙げられます。

個別化医療に対する需要の高まりが、今後数年間の腸内細菌叢市場の成長を促進すると予想されます。個別化医療は、健康転帰を最適化し、治療を改善するために、遺伝的、環境的、ライフスタイル的要因に基づいて個々の患者に合わせた治療を行うことを含みます。ゲノミクスとバイオテクノロジーの進歩により、遺伝子プロファイルをより正確に特定できるようになり、より的を絞った、より効果的で副作用の少ない治療が可能になるため、個別化医療への需要が高まっています。個別化医療は腸内細菌叢にとって特に有益です。個別化医療は、個人固有のマイクロバイオーム構成に基づいて治療をカスタマイズできるため、腸の健康を最適化し、消化器疾患や代謝疾患の予後を改善します。例えば、2024年2月、米国の非営利団体である個別化医療連合（PMC）は、米国食品医薬品局（FDA）が2023年に26の新しい個別化医薬品を承認したと報告しました。このように、個別化医療に対する需要の高まりが腸内細菌叢市場の拡大を後押ししています。

腸内細菌叢市場の主要企業は、さまざまな消化器疾患や障害に対処するため、経口投与糞便微生物叢などの革新的なソリューションに注力しています。糞便微生物群の経口投与は、健康なドナーの便から有益な細菌を含むカプセルや錠剤を摂取し、腸内細菌叢のバランスを回復させる。例えば、2023年4月、米国のマイクロバイオーム治療薬プラットフォーム企業であるセレス・セラピューティクス社は、18歳以上の成人におけるクロストリジオイデス・ディフィシル（C. difficile）感染症（CDI）の再発予防を目的とした初の経口糞便微生物製剤であるVowstのFDA承認を取得しました。Vowstは再発性CDIに対する抗菌薬治療後に使用することを意図しており、通常大腸内視鏡検査や浣腸によって投与される従来の糞便微生物叢移植に代わる、より利用しやすく患者に優しい選択肢を提供します。Vowstの経口製剤は、治療のアドヒアランスを向上させ、ヘルスケアにおけるマイクロバイオーム療法の幅広い採用を促進する可能性があります。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、貿易戦争と関税、そしてコロナ禍と回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界腸内細菌叢 PESTEL分析（政治、社会、技術、環境、法的要因、促進要因と抑制要因）
• 最終用途産業の分析
• 世界の腸内細菌叢市場：成長率分析
• 世界の腸内細菌叢市場の実績：規模と成長, 2019-2024
• 世界の腸内細菌叢市場の予測：規模と成長, 2024-2029, 2034F
• 世界腸内細菌叢総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の腸内細菌叢市場：製品別、実績と予測, 2019-2024, 2024-2029F, 2034F
• プレバイオティクス
• プロバイオティクス
• 薬物
• サプリメント
• その他の製品
• 世界の腸内細菌叢市場：流通チャネル別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 薬局とドラッグストア
• オンライン小売
• 健康食品店
• スーパーマーケットとハイパーマーケット
• 専門店
• 世界の腸内細菌叢市場：用途別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 消化器系の健康
• 免疫の健康
• 体重管理
• メンタルヘルス
• 心臓血管の健康
• 世界の腸内細菌叢市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 大人
• 子供
• お年寄り
• 世界の腸内細菌叢市場プレバイオティクスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• フルクトオリゴ糖（FOS）
• ガラクトオリゴ糖（GOS）
• イヌリン
• 難消化性デンプン
• ベータグルカン
• アラビノガラクタン
• ペクチン
• 世界の腸内細菌叢市場プロバイオティクスの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 乳酸菌
• ビフィズス菌
• サッカロミセス
• 連鎖球菌
• バチルス
• 大腸菌
• 世界の腸内細菌叢市場、薬物の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 抗生物質
• バクテリオファージ療法
• 腸内細菌叢モジュレーター
• 免疫調節薬
• 下痢止め薬
• 下剤
• 世界の腸内細菌叢市場サプリメントの種類別サブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• シンバイオティクス
• ポストバイオティクス
• 酵素サプリメント
• ビタミンDサプリメント
• オメガ3脂肪酸
• ハーブエキス
• 世界の腸内細菌叢市場、その他の製品のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 機能性食品
• 発酵食品
• 飲料
• 腸の健康診断キット
• 食物繊維製品

第7章 地域別・国別分析

• 世界の腸内細菌叢市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の腸内細菌叢市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 腸内細菌叢市場：競合情勢
• 腸内細菌叢市場：企業プロファイル
  • Danone S.A. Overview, Products and Services, Strategy and Financial Analysis
  • DuPont de Nemours Inc. Overview, Products and Services, Strategy and Financial Analysis
  • International Flavors & Fragrances Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Seres Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • Yakult Honsha Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Chr. Hansen Holding A/S
• Lallemand Inc.
• Lifeway Foods Inc.
• BioGaia AB
• Probi AB
• Seed Health
• Enterome
• Vedanta Biosciences Inc.
• Evolve BioSystems Inc.
• Winclove Probiotics B.V.
• Kallyope Inc.
• Sun Genomics Inc.
• Synlogic Inc.
• OpenBiome
• Codex Labs Corp.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 腸内細菌叢市場2029：新たな機会を提供する国
• 腸内細菌叢市場2029：新たな機会を提供するセグメント
• 腸内細菌叢市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Gut microbiota refers to the diverse community of microorganisms, including bacteria, viruses, fungi, and other microbes, that inhabit the gastrointestinal tract. These microbes play a crucial role in digestion, immune function, and overall health by influencing metabolism and offering protection against harmful pathogens.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The primary product types in the gut microbiota market include prebiotics, probiotics, drugs, supplements, and other products. Prebiotics are non-digestible food components, mainly dietary fibers, that serve as food for beneficial bacteria in the gut. These products are distributed through various channels such as pharmacies, drugstores, online retail, health food stores, supermarkets, hypermarkets, and specialty stores. They are used for a range of applications including digestive health, immune health, weight management, mental health, and cardiovascular health, and cater to different end-users, including adults, children, and the elderly.

The gut microbiota market research report is one of a series of new reports from The Business Research Company that provides gut microbiota market statistics, including gut microbiota industry global market size, regional shares, competitors with a gut microbiota market share, detailed gut microbiota market segments, market trends and opportunities, and any further data you may need to thrive in the gut microbiota industry. This gut microbiota market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The gut microbiota market size has grown rapidly in recent years. It will grow from$0.55 billion in 2024 to $0.65 billion in 2025 at a compound annual growth rate (CAGR) of 18.5%. The growth during the historic period can be attributed to the discovery of probiotics and prebiotics, the rise in gastrointestinal disorders, increasing interest in functional foods, the growing use of antibiotics, and heightened awareness of the gut-brain axis.

The gut microbiota market size is expected to see rapid growth in the next few years. It will grow to$1.27 billion in 2029 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to the expansion of personalized nutrition, rising demand for microbiome-based therapeutics, growth in functional and fermented foods, and regulatory support for probiotics and prebiotics. Major trends in the forecast period include AI-driven microbiome analysis, advancements in next-generation sequencing, CRISPR-based gut microbiota editing, development of smart probiotic delivery systems, and the emergence of wearable gut health monitoring devices.

The increasing demand for personalized medicine is expected to drive the growth of the gut microbiota market in the coming years. Personalized medicine involves tailoring treatments to individual patients based on their genetic, environmental, and lifestyle factors to optimize health outcomes and improve care. The demand for personalized medicine is growing as advancements in genomics and biotechnology enable more precise identification of genetic profiles, allowing for treatments that are better targeted, more effective, and have fewer side effects. Personalized medicine is particularly beneficial for gut microbiota, as it allows for the customization of treatments based on an individual's unique microbiome composition, optimizing gut health and improving outcomes for digestive and metabolic disorders. For example, in February 2024, the Personalized Medicine Coalition (PMC), a US-based nonprofit organization, reported that the U.S. Food and Drug Administration (FDA) approved 26 new personalized medicines in 2023, a significant increase compared to the 12 approvals in 2022. As such, the growing demand for personalized medicine is driving the expansion of the gut microbiota market.

Leading companies in the gut microbiota market are focusing on innovative solutions, such as orally administered fecal microbiota, to address various gastrointestinal diseases and disorders. Orally administered fecal microbiota involves taking a capsule or pill containing beneficial bacteria from a healthy donor's stool to restore balance to the gut microbiome. For example, in April 2023, Seres Therapeutics Inc., a US-based microbiome therapeutics platform company, received FDA approval for Vowst, the first oral fecal microbiota product designed to prevent recurrent Clostridioides difficile (C. difficile) infection (CDI) in adults aged 18 and older. Vowst is intended for use after antibacterial treatment for recurrent CDI, providing a more accessible, patient-friendly alternative to traditional fecal microbiota transplants, which are usually administered via colonoscopy or enema. The oral formulation of Vowst may improve treatment adherence and promote the broader adoption of microbiome-based therapies in healthcare.

In April 2023, Archer-Daniels-Midland Company (ADM), a US-based food processing company, partnered with Brightseed to develop scientifically backed synbiotic products that support gut microbiome health. This collaboration leverages Brightseed's AI-driven molecular insights to create evidence-based formulations that aim to enhance immune function, metabolic health, and mental well-being. By combining ADM's nutrition expertise with Brightseed's AI technology, the partnership is focused on advancing gut health solutions grounded in cutting-edge science. Brightseed, a US-based biotechnology company, specializes in gut microbiome research through its proprietary AI platform.

Major players in the gut microbiota market are Danone S.A., DuPont de Nemours Inc., International Flavors & Fragrances Inc., Seres Therapeutics, Yakult Honsha Co. Ltd., Chr. Hansen Holding A/S, Lallemand Inc., Lifeway Foods Inc., BioGaia AB, Probi AB, Seed Health, Enterome, Vedanta Biosciences Inc., Evolve BioSystems Inc., Winclove Probiotics B.V., Kallyope Inc., Sun Genomics Inc., Synlogic Inc., OpenBiome, and Codex Labs Corp.

North America was the largest region in the gut microbiota market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in gut microbiota report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the gut microbiota market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The gut microbiota market consists of sales of postbiotics, personalized nutrition products, and fecal microbiota transplantation (FMT) preparations. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Gut Microbiota Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on gut microbiota market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for gut microbiota ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The gut microbiota market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Prebiotics; Probiotics; Drugs; Supplements; Other Products
• 2) By Application: Digestive Health; Immune Health; Weight Management; Mental Health; Cardiovascular Health
• 3) By Distribution Channel: Pharmacies And Drugstores; Online Retail; Health Food Stores; Supermarkets And Hypermarkets; Specialty Stores
• 4) By End-Users: Adults; Children; Elderly
• Subsegments:
• 1) By Prebiotics: Fructooligosaccharides (Fos); Galactooligosaccharides (Gos); Inulin; Resistant Starch; Beta-Glucans; Arabinogalactans; Pectins
• 2) By Probiotics: Lactobacillus; Bifidobacterium; Saccharomyces; Streptococcus; Bacillus; Escherichia
• 3) By Drugs: Antibiotics; Bacteriophage Therapy; Gut Microbiota Modulators; Immunomodulators; Antidiarrheal Agents; Laxatives
• 4) By Supplements: Synbiotics; Postbiotics; Enzyme Supplements; Vitamin D Supplements; Omega-3 Fatty Acids; Herbal Extracts
• 5) By Other Products: Functional Foods; Fermented Foods; Beverages; Gut Health Diagnostic Kits; Dietary Fiber Products
• Companies Mentioned: Danone S.A.; DuPont de Nemours Inc.; International Flavors & Fragrances Inc.; Seres Therapeutics; Yakult Honsha Co. Ltd.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Gut Microbiota Market Characteristics

3. Gut Microbiota Market Trends And Strategies

4. Gut Microbiota Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Gut Microbiota Growth Analysis And Strategic Analysis Framework

• 5.1. Global Gut Microbiota PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Gut Microbiota Market Growth Rate Analysis
• 5.4. Global Gut Microbiota Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Gut Microbiota Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Gut Microbiota Total Addressable Market (TAM)

6. Gut Microbiota Market Segmentation

• 6.1. Global Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Prebiotics
• Probiotics
• Drugs
• Supplements
• Other Products
• 6.2. Global Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacies And Drugstores
• Online Retail
• Health Food Stores
• Supermarkets And Hypermarkets
• Specialty Stores
• 6.3. Global Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Digestive Health
• Immune Health
• Weight Management
• Mental Health
• Cardiovascular Health
• 6.4. Global Gut Microbiota Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Adults
• Children
• Elderly
• 6.5. Global Gut Microbiota Market, Sub-Segmentation Of Prebiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fructooligosaccharides (FOS)
• Galactooligosaccharides (GOS)
• Inulin
• Resistant Starch
• Beta-Glucans
• Arabinogalactans
• Pectins
• 6.6. Global Gut Microbiota Market, Sub-Segmentation Of Probiotics, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Lactobacillus
• Bifidobacterium
• Saccharomyces
• Streptococcus
• Bacillus
• Escherichia
• 6.7. Global Gut Microbiota Market, Sub-Segmentation Of Drugs, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Antibiotics
• Bacteriophage Therapy
• Gut Microbiota Modulators
• Immunomodulators
• Antidiarrheal Agents
• Laxatives
• 6.8. Global Gut Microbiota Market, Sub-Segmentation Of Supplements, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Synbiotics
• Postbiotics
• Enzyme Supplements
• Vitamin D Supplements
• Omega-3 Fatty Acids
• Herbal Extracts
• 6.9. Global Gut Microbiota Market, Sub-Segmentation Of Other Products, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Functional Foods
• Fermented Foods
• Beverages
• Gut Health Diagnostic Kits
• Dietary Fiber Products

7. Gut Microbiota Market Regional And Country Analysis

• 7.1. Global Gut Microbiota Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Gut Microbiota Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Gut Microbiota Market

• 8.1. Asia-Pacific Gut Microbiota Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Gut Microbiota Market

• 9.1. China Gut Microbiota Market Overview
• 9.2. China Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Gut Microbiota Market

• 10.1. India Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Gut Microbiota Market

• 11.1. Japan Gut Microbiota Market Overview
• 11.2. Japan Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Gut Microbiota Market

• 12.1. Australia Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Gut Microbiota Market

• 13.1. Indonesia Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Gut Microbiota Market

• 14.1. South Korea Gut Microbiota Market Overview
• 14.2. South Korea Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Gut Microbiota Market

• 15.1. Western Europe Gut Microbiota Market Overview
• 15.2. Western Europe Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Gut Microbiota Market

• 16.1. UK Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Gut Microbiota Market

• 17.1. Germany Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Gut Microbiota Market

• 18.1. France Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Gut Microbiota Market

• 19.1. Italy Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Gut Microbiota Market

• 20.1. Spain Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Gut Microbiota Market

• 21.1. Eastern Europe Gut Microbiota Market Overview
• 21.2. Eastern Europe Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Gut Microbiota Market

• 22.1. Russia Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Gut Microbiota Market

• 23.1. North America Gut Microbiota Market Overview
• 23.2. North America Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Gut Microbiota Market

• 24.1. USA Gut Microbiota Market Overview
• 24.2. USA Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Gut Microbiota Market

• 25.1. Canada Gut Microbiota Market Overview
• 25.2. Canada Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Gut Microbiota Market

• 26.1. South America Gut Microbiota Market Overview
• 26.2. South America Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Gut Microbiota Market

• 27.1. Brazil Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Gut Microbiota Market

• 28.1. Middle East Gut Microbiota Market Overview
• 28.2. Middle East Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Gut Microbiota Market

• 29.1. Africa Gut Microbiota Market Overview
• 29.2. Africa Gut Microbiota Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Gut Microbiota Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Gut Microbiota Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Gut Microbiota Market Competitive Landscape And Company Profiles

• 30.1. Gut Microbiota Market Competitive Landscape
• 30.2. Gut Microbiota Market Company Profiles
  • 30.2.1. Danone S.A. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. DuPont de Nemours Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. International Flavors & Fragrances Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Seres Therapeutics Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Yakult Honsha Co. Ltd. Overview, Products and Services, Strategy and Financial Analysis

31. Gut Microbiota Market Other Major And Innovative Companies

• 31.1. Chr. Hansen Holding A/S
• 31.2. Lallemand Inc.
• 31.3. Lifeway Foods Inc.
• 31.4. BioGaia AB
• 31.5. Probi AB
• 31.6. Seed Health
• 31.7. Enterome
• 31.8. Vedanta Biosciences Inc.
• 31.9. Evolve BioSystems Inc.
• 31.10. Winclove Probiotics B.V.
• 31.11. Kallyope Inc.
• 31.12. Sun Genomics Inc.
• 31.13. Synlogic Inc.
• 31.14. OpenBiome
• 31.15. Codex Labs Corp.

32. Global Gut Microbiota Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Gut Microbiota Market

34. Recent Developments In The Gut Microbiota Market

35. Gut Microbiota Market High Potential Countries, Segments and Strategies

• 35.1 Gut Microbiota Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Gut Microbiota Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Gut Microbiota Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer
• 250617_r34863_Gut_Microbiota_GMR_2025